Are Pain Management Claims Being Paid Correctly in 2026?

The short answer: for most pain management practices, no. Significant revenue is leaking through miscoded procedures, missing modifiers, failed prior authorizations, and RTM billing gaps — and 2026's regulatory updates have made the stakes considerably higher.

In 2026, CMS and commercial payers have intensified scrutiny on interventional pain procedures — including epidural injections, nerve blocks, facet joint injections, and radiofrequency ablations — with new documentation thresholds, prior authorization mandates, and CPT code restructuring that most in-house billing teams are not equipped to navigate.

For multi-physician pain management groups generating $5M+ in annual collections, this translates to six-figure revenue leakage that persists quarter after quarter. If your case volume is holding steady but collections are flat or declining, the problem is almost certainly in your Pain Management Billing Services infrastructure — not your clinical throughput.

The Triple Threat to Pain Management Reimbursement in 2026

1. RTM Code Restructuring — New Codes, New Denial Vectors

Effective January 1, 2026, CMS finalized major changes to Remote Therapeutic Monitoring under the CY 2026 Physician Fee Schedule Final Rule (CMS-1807-F). Two new CPT codes — 98985 (device supply for 2-15 days of musculoskeletal monitoring) and 98979 (10-19 minutes of treatment management time) — significantly expand what is billable for pain practices, but only for those who updated charge capture templates, EHR documentation workflows, and payer eligibility rules before Q1.

Practices still billing under legacy RTM thresholds (16-day minimum device supply, 20-minute minimum management time) are either leaving revenue on the table or submitting claims that misrepresent services rendered. Either outcome triggers payer scrutiny. The 2026 national average reimbursement for 98980 is $54.11 (Non-APM) — a direct revenue recovery opportunity per chronic pain patient per month.

2. Expanded Prior Authorization for Interventional Procedures

In 2026, commercial payers across major markets — including Florida, Texas, New York, and California — have expanded prior authorization requirements for neuromodulation implants, pharmacogenomic tests, and repeat interventional pain procedures. Missing or expired authorizations result in automatic denials regardless of medical necessity. This is not a documentation problem — it is a workflow infrastructure problem.

For practices performing spinal cord stimulator implants billed with HCPCS C1607 (newly standardized in 2026 for implantable integrated neurostimulator devices), a single authorization failure on a $25,000+ procedure erases months of margin. Proactive payer-policy trackers and clearinghouse edit rules are not optional in 2026 — they are revenue protection infrastructure.

3. ICD-10 Sequencing Errors Triggering Bundling Denials

The FY 2026 ICD-10-CM update introduced new granular codes for abdominal, pelvic, perineal, and chronic pain documentation — expanding precision requirements for claims that previously passed on broader legacy codes. Incorrect sequencing between chronic pain management codes (99491, 99437) and same-day psychotherapy codes now triggers bundling edits under CMS NCCI policy, an issue particularly acute for pain practices serving behavioral health-comorbid populations.

2026 Pain Management Billing: Denial Risk by Procedure Category

What Correct Pain Management Claims Look Like in 2026

Correctly paid pain management claims in 2026 share five operational characteristics that most practices lack the internal infrastructure to sustain:

• Real-time prior authorization tracking by CPT code and payer, updated as 2026 commercial policy expansions roll out by market
• Charge capture templates updated to include new RTM codes 98985 and 98979 with correct documentation triggers
• Modifier governance protocols preventing bilateral modifier errors on facet injections (LT/RT vs. 50) that trigger automatic downcoding
• ICD-10 sequencing validation that separates chronic pain management codes from same-day behavioral health codes to avoid NCCI bundling edits
• LCD compliance monitoring for radiofrequency ablations — particularly MAC-specific coverage articles that vary by state

The practices achieving 94%+ clean claim rates in pain management are not doing this manually. They have revenue cycle infrastructure — claim scrubbing logic, payer-specific edit libraries, and denial root-cause analytics — that functions before the claim leaves the building, not 45 days later during appeals.

The Revenue Leakage Most Pain Practices Never Quantify

Industry data shows 5%-10% claim denial rates across pain management, with nearly 60% of denied claims never recovered. For a pain management group billing $4M annually, a 7% denial rate with 60% permanent write-off represents $168,000 in annual revenue that disappears without appearing on any P&L line item — because it was never collected in the first place.

The leakage compounds in three directions: unbilled RTM services under new 2026 codes, written-off interventional denials that were never appealed with corrected documentation, and underutilization of CCM code stacking.

CMS confirmed a 10% reimbursement increase for all CCM codes in 2026 under the final rule. Chronic pain patients with two or more qualifying conditions represent a monthly recurring revenue stream most practices are not capturing — and that gap widens every billing cycle it goes unaddressed.

Request a Pain Management Revenue Integrity Review

MBC's Pain Management Billing Services team conducts specialty-specific claim audits, RTM compliance assessments, and payer authorization gap analyses for multi-physician pain groups. If your collections are not reflecting your clinical volume, the gap is quantifiable — and recoverable.

Call: 888-357-3226 | Email: info@medicalbillersandcoders.com